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O2Hb by 2.2 ± 1.2 μmol (p < 0.05 vs. resting normoxia); 
hypoxic exercise further lowered it to −7.6 ± 3.1 μmol 
below baseline (p < 0.05). cerebral HHb, increased by 
3.5 ± 1.8 μmol in resting hypoxia (p < 0.05), and further 
to 8.5 ± 2.9 μmol in hypoxic exercise (p < 0.05). changes 
in cBF and cerebral tissue oxygenation during rt did not 
correlate with tt performance loss (R = 0.4, p > 0.05 and 
R = 0.5, p > 0.05, respectively), while tissue oxygenation 
and SaO2 changes during tt did (R = −0.76, p < 0.05). 
Significant correlations were observed between SaO2, 
McAv and HHb during rt (R = −0.77, −0.76 and 0.84 
respectively, p < 0.05 in all cases).
Conclusions cBF and cerebral tissue oxygenation 
changes during rt do not predict performance impairment 
in hypoxia. Since the changes in SaO2 and brain HHb dur-
ing the tt correlated with performance impairment, the 
hypothesis that brain oxygenation plays a limiting role for 
global exercise in conditions of severe hypoxia remains to 
be tested further.
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Introduction
Acute hypoxia impairs peak aerobic power (i.e., maximum 
oxygen consumption, V˙O2peak) and hinders optimal per-
formance in global exercises (e.g., running or cycling) such 
as time-to-exhaustion, time-trial, and maximum distance 
covered in a given time [see roach and Kayser (2001) 
for review]. Studies have tried to identify the underlying 
mechanisms of this impairment (lawler et al. 1988; Fer-
retti et al. 1997; Woorons et al. 2007; Amann and Kayser 
2009; calbet et al. 2009). two consensuses arise from these 
Abstract 
Background the richalet hypoxia sensitivity test (rt), 
which quantifies the cardiorespiratory response to acute 
hypoxia during exercise at an intensity corresponding to a 
heart rate of ~130 bpm in normoxia, can predict suscepti-
bility of altitude sickness. Its ability to predict exercise per-
formance in hypoxia is unknown.
Objectives Investigate: (1) whether cerebral blood flow 
(cBF) and cerebral tissue oxygenation (O2Hb; oxygenated 
hemoglobin, HHb; deoxygenated hemoglobin) responses 
during rt predict time-trial cycling (tt) performance in 
severe hypoxia; (2) if subjects with blunted cardiorespira-
tory responses during rt show greater impairment of tt 
performance in severe hypoxia.
Study design thirteen men [27 ± 7 years (mean ± SD), 
Wmax: 385 ± 30 W] were evaluated with rt and the 
results related to two 15 km tt, in normoxia and severe 
hypoxia (FIO2 = 0.11).
Results During rt, mean middle cerebral artery blood 
velocity (McAv: index of cBF) was unaltered with 
hypoxia at rest (p > 0.05), while it was increased during 
normoxic (+22 ± 12 %, p < 0.05) and hypoxic exercise 
(+33 ± 17 %, p < 0.05). resting hypoxia lowered cerebral 
communicated by carsten lundby.
n. Bourdillon (*) · J.-l. Fan · B. Kayser 
ISSUl institute of Sport Sciences, University of lausanne, 
lausanne 1015, Switzerland
e-mail: nicolas.bourdillon@gmail.com
B. Kayser 
e-mail: Bengt.Kayser@unil.ch
J.-l. Fan 
lemanic neuroscience Doctoral School, University of lausanne, 
lausanne, Switzerland
1038 Eur J Appl Physiol (2014) 114:1037–1048
1 3
studies: first, people with higher V˙O2peak in normoxia are 
more adversely affected (Martin and O’Kroy 1993; gore 
et al. 1996; Ferretti et al. 1997; Woorons et al. 2007; cal-
bet and lundby 2009); and second, this is due to a greater 
drop in arterial oxygen saturation (SaO2), arterial oxy-
gen content (caO2), and mass O2 transport (Ekblom et al. 
1975; chapman et al. 1999; Woorons et al. 2007; calbet 
and lundby 2009), leading to an early onset of muscle 
fatigue and exhaustion (Amann and Kayser 2009). In mod-
erate hypoxia, maximum cardiac output is similar to that 
in normoxia, which supports the notion that mass cardio-
vascular oxygen transport is a main limiting factor. But in 
more severe hypoxia (SaO2 < 75 %), peak heart rate and 
cardiac output are blunted at maximal exercise, while there 
is less muscle fatigue at the point of exhaustion, suggest-
ing early limitation of motor drive and disengagement from 
the effort before the advent of important peripheral mus-
cle fatigue (Kayser 2003; Amann et al. 2007; Amann and 
Kayser 2009; calbet and lundby 2009; Seifert et al. 2010; 
Subudhi et al. 2011).
near infrared spectroscopy (nIrS) allows for the con-
tinuous measure of oxy- and deoxyhemoglobin concen-
trations in brain tissue thus potentially giving precious 
information on the oxygenation status during exercise 
and exposure to hypoxia (Bourdillon and Perrey 2012). 
Exposure to hypoxia at rest lowers prefrontal cortex tissue 
oxygenation, while global exercise in normoxia elevates it 
(rupp and Perrey 2008; Smith et al. 2012). Since combina-
tion of global exercise and hypoxia reduces cerebral tissue 
oxygenation (rupp and Perrey 2008; Subudhi et al. 2008; 
Bourdillon et al. 2009; Verges et al. 2012), some authors 
speculated that this reduction might limit global exercise 
capacity and performance in hypoxia (Amann et al. 2007; 
Subudhi et al. 2009; Amann and Kayser 2009; rasmus-
sen et al. 2010). In agreement with this contention, during 
exercise in severe hypoxia, administration of supplemental 
oxygen at the point of exhaustion rapidly improves cere-
bral oxygenation, improving peak power output (Subudhi 
et al. 2009; Koglin and Kayser 2013) and time to exhaus-
tion (Kayser et al. 1994; Amann et al. 2007). Since this 
shift is too quick to result from reversal of the accrual or 
depletion of metabolites associated with muscle fatigue, it 
was suggested that the improvement in performance may 
be mediated by improved cerebral oxygen delivery (Kay-
ser et al. 1994; Amann et al. 2007; Subudhi et al. 2009).
cerebral oxygen delivery is the product of cerebral blood 
flow (cBF) and caO2. In normoxia, submaximal global 
exercise increases middle cerebral artery blood veloc-
ity (McAv) and presumably blood flow (Jørgensen et al. 
1992; Madsen et al. 1993; Ide et al. 1999). Hypoxemia per 
se leads to cerebral vasodilation, while hyperventilation-
induced hypocapnia associated with hypoxemia causes 
cerebral vasoconstriction (Ainslie and Ogoh 2010). the net 
effect of exposure to hypoxia on cBF depends on the sum 
of these opposing drives (Peltonen et al. 2007; nishimura 
et al. 2010). Whether cBF and cerebral oxygenation play 
a limiting role in exercise performance in hypoxia remains 
unclear (Subudhi et al. 2008; Peltonen et al. 2009; Subudhi 
et al. 2011; Verges et al. 2012; Fan and Kayser 2013).
the extent of hypoxemia and hypocapnia upon acute 
exposure to hypoxia is function of the hypoxic ventilatory 
response, defined as the increase in ventilation in hypoxic 
conditions, through the stimulation of the peripheral 
chemoreceptors. For acclimatization to high altitude and 
mountaineering performance, a strong hypoxic ventilatory 
response (i.e., large increase in ventilation) is thought to be 
a factor for success, but may also increase the risk of brain 
damage because of excessive hyperventilation hypocapnia-
induced cerebral hypoxemia (Hornbein et al. 1989). In 
contrast, findings by Bernardi et al. (2006) suggest that a 
blunted ventilatory response to hypoxia gives acclimatized 
elite climbers more respiratory reserve, which would allow 
them to perform better at extreme altitude.
richalet et al. (1983, 2012) developed a hypoxia sen-
sitivity test and reported that a blunted cardiorespiratory 
response to hypoxia during cycling exercise (at an inten-
sity reaching a heart rate of ~130 bpm in normoxia) pre-
dicts risk for acute mountain sickness (AMS). cBF and 
cerebral tissue oxygenation responses during this test have 
not yet been reported. We hypothesized that a brisk cBF 
response during a richalet test would protect cerebral tis-
sue oxygenation and be accompanied by less impairment 
of cycling time-trial performance in severe hypoxia, while 
a brisk ventilatory response to hypoxia would impede cer-
ebral oxygenation and impair time-trial performance. to 
test these hypotheses, we measured cBF with transcranial 
Doppler and prefrontal cerebral cortex oxygenation with 
nIrS during a richalet test in unacclimatized subjects and 
related the changes with the subjects’ all-out 15 km time-
trial (tt) cycling performances in normoxia and acute nor-
mobaric hypoxia.
Methods
Participants
thirteen healthy male subjects participated in this study [age: 
27 ± 7 years (mean ± SD); body mass index: 22.3 ± 1.3 kg/m2, 
and Wmax: 385 ± 30 W]. All were trained amateur cyclists 
living in geneva, Switzerland (389–450 m) and not acclima-
tized to high altitude. they were non-smokers, had no previ-
ous history of cardiovascular, cerebrovascular, or respiratory 
disease and were not taking any medication at the time of 
the study. Informed written consent was obtained from the 
subjects prior to their participation. the study was approved 
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by the research Ethical committee of the University Hos-
pitals of geneva and conformed to the standards set by the 
Declaration of Helsinki.
Experimental design
In the context of another study (Fan et al. 2013) the par-
ticipants had three laboratory visits. the first visit included 
familiarization (which included adjustment of bike settings 
and familiarization with all devices and procedures used for 
the experiments), and the richalet hypoxia sensitivity test 
(described below), followed by an incremental ramp test on 
a cycle ergometer (Ergoselect 100, Ergoline gmbH, Bitz, 
germany). the participants then returned on two separate 
days to perform a 15 km tt in either normoxia (ambient 
air at 389 m) or hypoxia (normobaric, FIO2 = 0.11, equiva-
lent of an altitude of ~5,000 m) in a randomized, balanced, 
single-blind design. the tests were separated by three to 
fourteen days. Before each experimental session, the par-
ticipants were asked to abstain from caffeine for 12 h, and 
heavy exercise and alcohol for 24 h. Each time-trial ses-
sion comprised of 20 min of instrumentation followed by 
a 2-min resting baseline collection with the participants 
breathing room air. they were seated on a racing bicycle 
fitted to a computrainer Pro model trainer (racerMate, 
Seattle, WA, USA), which was calibrated prior to each 
session according the manufacturers’ instruction manual. 
While breathing room air, the subjects were asked to per-
form a 5-min self-selected warm-up exercise with heart 
rate <130 bpm. they then rested for 5 min after which they 
were switched to breathe from a gas mixing system (Alti-
trainer, SMtec, nyon, Switzerland) for another 4-min rest-
ing baseline collection. the participants were instructed to 
perform a 15 km tt cycling as fast as possible. they were 
free to shift gears during tt and constant feedback regard-
ing the distance was provided on a monitor by means of a 
cursor along a horizontal bar and a countdown distance dis-
play (computrainer 3D software version 3.0, racermate). 
time-trial performance was expressed as the time spent to 
cover the 15 km as well as the average power output during 
the tt. throughout all three experimental sessions, the par-
ticipants wore a nose-clip and breathed through a mouth-
piece attached to a low resistance one-way non-rebreath-
ing valve (Hans-rudolph 2700, Kansas city, MO, USA). 
Hypoxia was achieved attaching the gas mixing system to 
the inspiratory valve of the mouthpiece using low resist-
ance tubing. the device consists of a reservoir in which 
air and experimental gasses are mixed and from which 
the participant inspires. During the time-trials the fraction 
of inspired O2 (FIO2) was kept constant at either 0.21 or 
0.11, corresponding to sea level and an altitude of 5,000 m, 
respectively. the participants always breathed through the 
same circuit, were kept naive to what gas mixture they 
were breathing, and were not informed in detail about the 
rationale of the study. For each participant, the experiments 
were carried out at the same time of day under consistent 
laboratory conditions (temperature 21 ± 1 °c, humidity 
32 ± 5 %, barometric pressure 726 ± 6 mmHg).
richalet test
Figure 1 shows the richalet hypoxia sensitivity test (rich-
alet et al. 2012) of which we performed the four 4-min 
steps: (a) resting normoxia (rn); (b) resting hypoxia (rH; 
FIO2 = 11 %); (c) hypoxic exercise (EH); and (d) nor-
moxic exercise (En). Mechanical power output on the cycle 
ergometer was adjusted at the beginning of the first cycling 
phase to attain a heart rate (Hr) at around 120–130 bpm in 
hypoxia and then kept constant (corresponding to 37 ± 7 % 
of maximal normoxic power output). Arterial oxygen satura-
tion from pulse oximetry (SpO2), ventilation (V˙E) and Hr 
variations between phases were used to characterize sub-
jects’ sensitivity to hypoxia (richalet et al. 2006, 2012) by 
calculating:
Desaturation at rest: ∆Spr = Sprn− Sprh (%)
Desaturation at exercise: ∆Spe = Spen − Speh (%)
Ventilation changes at rest: ∆V˙Er = V˙Erh−V˙ Ern (1/min);
Ventilation changes at exercise:  
∆V˙Ee = V˙Eeh − V˙Een(1/min);
Fig. 1  Hypoxia exercise test, modified from richalet et al. (2012). 
RN rest in normoxia, RH rest in hypoxia, EH exercise in hypoxia, EN 
exercise in normoxia. Hypoxia was produced by breathing a normo-
baric hypoxic gas mixture (FIO2 = 0.115). Exercise was performed at 
approximately 37 ± 7 % of maximal power output in phases EH and 
En. Ventilatory response to hypoxia during exercise (HVre); Arte-
rial oxygen saturation (Sa, SaO2); Arterial oxygen saturation during 
rest (Sae); Arterial oxygen saturation during exercise (Sar); pulmo-
nary ventilation (V˙Ee); Pulmonary ventilation during exercise (V˙Ee). 
Dotted line, V˙E; solid line, Sa. reprinted with permission of the 
American thoracic Society. copyright © 2014 American thoracic 
Society (richalet et al. 2012). Official Journal of the American 
thoracic Society
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Ventilatory response at rest:  
HVRr = ∆V˙Er/∆Spr/BW (l/min/kg);
Ventilatory response at exercise: 
HVRe = ∆V˙Ee/∆Spe/BW (l/min/kg);
cardiac response at rest:  
HCRr = (HRrh−HRrn)/∆Spr (beats/min/ %);
cardiac response during exercise: 
HCRe = (HReh−HRen)/∆Spr (beats/min/ %).
Sp = O2 saturation, Hr = heart rate, V˙E = ventilation, 
BW = body weight, r = rest, e = exercise, n = normoxia, 
h = hypoxia.
Measurements
Respiratory variables
gas exchange was monitored breath-by-breath (Medgraph-
ics cPX, St Paul, Mn, USA) measuring flow at the mouth 
(Pitot tube). Fractions of inspired and expired O2 and cO2 
were recorded with fast responding gas analysers (infrared 
and paramagnetic) integrated in the system. Ventilation was 
calculated from the flow signal and expressed in l.min−1 
BtPS. Partial pressures of end-tidal O2 (PetO2) and cO2 
(PetcO2) were also measured by the gas analysis system. 
Prior to each experimental session, the system was cali-
brated using a 3-l syringe (M9474, Medikro Oy, Finland) 
and gas mixtures of known O2 and cO2 concentrations.
Cerebrovascular variables
Middle cerebral artery blood flow velocities (McAv) 
were measured bilaterally using a 2-MHz pulsed Dop-
pler ultrasound system (St3, Spencer technology, Seat-
tle, WA, USA). the probes were positioned over the tem-
poral windows and held firmly in place with an adjustable 
head frame (Marc 600, Spencer technology, Seattle, WA, 
USA). the signals were acquired at depths ranging from 43 
to 54 mm. Signal quality was optimized and an M-mode 
screen shot was recorded to facilitate subsequent probe 
placements. Depth and velocity of McAv signals were 
recorded and compared between sessions to ensure within-
subject repeatability. In our hands, day-to-day reproduc-
ibility of McAv has a coefficient of variation of <10 %. 
Bilateral McAv were averaged to represent an index of 
overall cBF. cerebral oxygenation in the left prefrontal 
lobe was assessed by monitoring changes in oxy-, deoxy- 
and total hemoglobin (O2Hb, HHb and tHb, respectively), 
obtained with spatially resolved, continuous wave nIrS 
(Artinis, Oxymon MKIII, Zetten, the netherlands). the 
nIrS probe was centered on the Fp1 point according to the 
EEg 10-20 system, i.e., 10 % of the nasion-vertex-inion 
distance, up from the nasion; and 10 % of the nasion-tem-
poral-inion distance, left from the nasion. nIrS measures 
changes in infrared light attenuation diffusing through tis-
sue. Positioned over the scalp, this non-invasive device 
allows monitoring of regional changes in cerebral hemo-
dynamics and reflects local tissue oxygenation. the signals 
reflect variations in concentrations of O2Hb, HHb and tHb 
in brain blood vessels (arterioles, capillaries, venules and 
veins), not O2 in the tissue itself. Source-detector spacing 
was set at 4.1 cm and data obtained from the optode was 
used to calculate changes with regard to baseline resting 
conditions in O2Hb, HHb and tHb with a differential path 
length factor computed according to the subjects’ age (van 
der Zee et al. 1992). All reported concentrations of O2Hb, 
HHb and tHb are changes with regard to normoxic resting 
baseline. For the richalet test the resting baseline was set 
at 0 during the rn phase.
Cardiovascular variables
Beat-to-beat mean arterial blood pressure (MAP) was 
monitored using finger photoplethysmography (Finometer-
MIDI, Finapress Medical Systems, Amsterdam, the neth-
erlands). From the MAP traces, beat-to-beat Hr was cal-
culated (labchart version 7.2, ADInstruments, Bella Vista, 
Australia). Peripheral O2 saturation (SpO2) was measured 
with a pulse oximeter (radical-7™, Masimo corporation, 
Irvine, cA, USA) on the right earlobe after application of 
a hyperaemia-inducing ointment (Decontractyl, Sanofi-
Aventis, Paris, France). Arterialized blood gas samples of 
75 μl were taken from the other ear lobe of the subjects 
during baseline, and at the 5th, 10th and 15th km of the tt. 
Samples were immediately analyzed on a rapidlab 248 
(Siemens, Erlangen, germany) for PaO2, PacO2, and pH, 
with [HcO3-] and SaO2 calculated by the system.
Data were acquired using an analogue-to-digital con-
verter (Ml880, Powerlab 16/30, ADInstruments, Bella 
Vista, Australia) with commercially available software 
(labchart version 7.2, ADInstruments, Bella Vista, Aus-
tralia), and stored on a computer for analysis. With the 
exception of the blood samples, all variables were recorded 
continuously at 200 Hz throughout the richalet test and the 
15 km tt tests.
Data and statistical analysis
From the richalet tests the average data obtained in the last 
30 s of the 4-min phases were used. Data are reported as 
mean ± SD. A paired t test (p < 0.05) was used to com-
pare normoxic and hypoxic 15 km time-trial times, average 
power output, Hr and SpO2. repeated-measures AnOVA 
with an alpha level of p < 0.05 were used to compare the 
30 s means at each kilometer of the tt for these vari-
ables (Matlab r2013b, MathWorks®, natick, MA, USA). 
Differences between phases of the richalet test were also 
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assessed using repeated-measures AnOVA with an alpha 
level of p < 0.05. Post hoc analysis of significant results 
from the AnOVAs was performed through Fischer’s lSD. 
correlation between variables was quantified by Pearson 
product (R = σxy/(σx. σy) with σxy covariance between 
parameters x and y; σx and σy standard deviations of 
parameters x and y) using Matlab.
Results
the main parameters during the four phases of the richalet 
test are summarized in Fig. 2 and typical traces of McAv 
and nIrS variables are shown in Fig. 3. resting hypoxia 
tended to increase V˙E (p > 0.05), while normoxic exercise, 
corresponding to 37 ± 7 % of maximum aerobic work 
capacity in normoxia, increased it by 22 ± 7 l/min (12 ± 3 
vs. 34 ± 5 l/min, p < 0.05); hypoxic exercise furthered 
this increase by 36 ± 10 l/min (12 ± 3 vs. 48 ± 9 l/min, 
p < 0.05 vs. resting normoxia, Fig. 2a). Hypoxia at rest 
lowered SpO2 by 11 ± 3 % (p < 0.05 vs. resting normoxia). 
the normoxic exercise did not decrease SpO2 (p > 0.05 vs. 
resting normoxia), while hypoxic exercise lowered SpO2 by 
27 ± 5 % (p < 0.05, Fig. 2b). resting hypoxia tended to 
increase Hr by 11 ± 4 bpm (p > 0.05); Hr was increased 
by 36 ± 10 bpm during normoxic exercise (p < 0.05 vs. 
resting normoxia), while the hypoxic exercise increased 
Hr by 55 ± 9 (p < 0.05 vs. resting normoxia, Fig. 2c). the 
patterns of change of those three parameters corresponded 
to those described by richalet et al. (2006, 2012). 
resting hypoxia decreased PetcO2 by 3.6 ± 1.2 mmHg 
(p < 0.05), while normoxic exercise increased PetcO2 
by 5.5 ± 1.9 mmHg (p < 0.05). Hypoxic exercise did not 
change PetcO2 as compared to resting hypoxia (p > 0.05, 
Fig. 2h).
Mean BP was modified by exercise only (p < 0.05), 
while hypoxia had no effect (p > 0.05, Fig. 2i).
Mean McAv was unaltered with resting hypoxia 
(p > 0.05), while it was increased during normoxic exercise 
(by 22 ± 12 %, p < 0.05) and to an even greater extent 
during hypoxic exercise (by 33 ± 17 %, p < 0.05, Figs. 2g 
and 3).
the nIrS data for one subject were lost due to a tech-
nical issue (n = 12). O2Hb followed the same trend as 
SpO2, decreasing by 2.2 ± 1.2 μmol in resting hypoxia 
(p < 0.05), while hypoxic exercise during the richalet test 
further lowered cerebral O2Hb to −7.6 ± 3.1 μmol from 
baseline (p < 0.05, Figs. 2d, 3). In contrast, normoxic exer-
cise had no effect on cerebral O2Hb (p > 0.05). cerebral 
HHb showed mirror changes compared to cerebral O2Hb, 
increasing by 3.5 ± 1.8 μmol in hypoxic rest (p < 0.05 
vs. normoxic rest). Hypoxic exercise increased cerebral 
HHb by 8.5 ± 2.9 μmol (p < 0.05), while normoxic exer-
cise had no effect (p > 0.05, Figs. 2e, 3). cerebral tHb did 
not change throughout the four phases of the richalet test 
(Fig. 2f).
Fig. 2  changes in parameters 
during the four phases of the 
richalet hypoxic sensitivity 
test. RN resting normoxia, RH 
resting hypoxia, EH hypoxic 
exercise, EN normoxic exercise. 
Hypoxia was simulated at an 
altitude equivalent to 4,800 m; 
exercise intensity was set at 
130 bpm during the hypoxic 
exercise. Ventilation (V˙E); Pulse 
oxygen saturation (SpO2); HR 
heart rate, Oxyhemoglobin con-
centration (O2Hb); Deoxyhemo-
globin concentration (HHb); 
Mean middle cerebral artery 
blood flow velocity (McAv); 
Partial pressure of end-tidal 
cO2 (PetcO2); Mean blood 
pressure (mean BP). Asterisks 
different from rn (p < 0.05); 
filled circle different from rH 
(p < 0.05); dagger different 
from EH (p < 0.05)
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Mean HVre was 0.77 ± 0.41 l/min/kg and mean HVrr 
was 0.50 ± 0.51 l/min/kg. none of our subjects were below 
richalet’s thresholds for normal values (richalet et al. 
2006). neither HVre nor HVrr correlated with the perfor-
mance decrement in hypoxic tt (R = 0.12, 0.08 respec-
tively, p > 0.05 for both).
SpO2 and McAv correlated well during the hypoxic 
phases of the richalet test (rH vs. EH, r = −0.77, 
p < 0.05, Fig. 4).
there were good correlations for the McAv and cer-
ebral HHb changes between normoxic and hypoxic exer-
cise (R = 0.76, p < 0.05, n = 12, Fig. 5b) and between 
hypoxic rest and hypoxic exercise (R = 0.76, p < 0.05, 
n = 12, Fig. 5a) during the richalet test. A similar trend 
was found for SpO2 and cerebral HHb between normoxic 
versus hypoxic exercise (R = −0.64, p = 0.05, n = 12) and 
between hypoxic rest and hypoxic exercise (R = −0.76, 
p < 0.05 n = 12).
time to complete the 15 km increased in hypoxia by 
20.2 ± 6.2 % (1,904 ± 75 s vs. 1,581 ± 60 s; p < 0.05).
SaO2 at the 5th, 10th, and 15th km, along with Hr, and 
power output at each kilometer during the tt in normoxia 
and hypoxia are reported on Fig. 6 (n = 11, due to difficul-
ties in blood sampling from two subjects). Hr was higher 
at rest in hypoxia (p < 0.05), but lower during the last 3 km 
of the trials (p < 0.05). Power output and SaO2 were lower 
in hypoxia at all times (p < 0.05 for both).
Figure 7a shows the correlation between the mean drop 
in SaO2 and the drop in performance during the 15 km tt 
(R = 0.64, p < 0.05, n = 11). Figure 7b shows the cor-
relation between mean brain HHb during the tt and the 
drop in performance (R = 0.62, p < 0.05). there was no 
Fig. 3  typical traces of McAv 
and nIrS measurements during 
the four phases of the richalet 
test. RN rest in normoxia, RH 
rest in hypoxia, EH exercise in 
hypoxia, EN exercise in nor-
moxia. Middle cerebral artery 
blood flow velocity (McAv). 
the upper boundary represents 
peak systolic flow, the lower 
boundary end-diastolic flow; 
Oxyhemoglobin concentration 
(O2Hb); Deoxyhemoglobin 
concentration (HHb)
Fig. 4  correlation between changes in O2 saturation and cere-
bral blood flow velocity during the RH resting hypoxia and the EH 
hypoxic exercise phases of the richalet test (cf. Fig. 1). Pulse oxy-
gen saturation (SpO2); Middle cerebral artery blood flow velocity 
(McAv)
1043Eur J Appl Physiol (2014) 114:1037–1048 
1 3
correlation between mean McAv during the tt and the 
drop in performance.
Discussion
the variations in SpO2, McAv and prefrontal brain HHb 
between the phases of the richalet test correlated with 
each other, but not with the tt performance decrement in 
hypoxia, which refutes our first hypothesis. there was also 
no correlation between the hypoxic ventilatory response as 
quantified by the richalet test (HVrr and HVre) and the 
impairment of tt performance, which refutes our second 
hypothesis. conversely, the changes in SaO2 and of pre-
frontal brain HHb during the tt were correlated with the 
drop in tt performance, suggesting that mass oxygen sup-
ply to the brain during the tt was limited by the exposure 
to hypoxia, thus leaving the hypothesis that brain oxygena-
tion may play a limiting role for global exercise in condi-
tions of severe hypoxia to be tested further.
cerebral blood flow and oxygenation during the richalet 
test
Prefrontal cortex O2Hb was decreased by hypoxia and fur-
ther reduced with exercise and hypoxia combined (Figs. 2d, 
3). this reduction in O2Hb coincided with increased pre-
frontal HHb while tHb remained unchanged (Fig. 2f), 
indicating reduced prefrontal cortex oxygenation (Figs. 2d–
f, 3). McAv and HHb correlated during the richalet test 
(Fig. 5a, b). Since the nIrS data consistently showed 
reduced oxygenation during hypoxic exercise, the increase 
in cBF (as estimated by McAv) was insufficient to prevent 
the drop in cerebral tissue oxygenation. As suggested by 
Verges et al. (2012), the balance between O2 delivery and 
utilization in the prefrontal cortex was probably modified 
towards a lower level of oxygenation during exercise in 
hypoxia. the reduction in cerebral O2 delivery, potentially 
associated with an increased cerebral metabolic rate dur-
ing whole-body exercise in hypoxia (Subudhi et al. 2007), 
would thus account for the reduced O2Hb. However, since 
nIrS assesses changes in deoxygenation in both pre- and 
post-capillary areas, it is also possible that oxygen extrac-
tion might have been increased (Brugniaux et al. 2007; 
Smith et al. 2013).
the changes in McAv and nIrS variables during the 
richalet test did not correlate to tt performance. Profound 
hypoxemia (SaO2 < 75 %) is thought to limit performance 
through a shift from predominantly peripheral muscle 
fatigue towards a cnS based inhibitory effect on central 
motor drive (Amann et al. 2007; Amann and Kayser 2009; 
rasmussen et al. 2010). It is likely that the limited hypox-
emia during the richalet test was of insufficient magnitude 
to limit central motor output. Moreover, the intensity of 
exercise during the richalet test, corresponding to ~50–
60 % of peak hypoxic aerobic capacity, probably did not 
sufficiently challenge mass oxygen transport to muscle and 
brain. As such, subjects with a greater decrease in SpO2 
during the richalet test showed a greater increase in McAv 
and HHb (Figs. 4, 5), but these changes do not provide 
insight to the variations in McAv and HHb up to maximal 
exercise, nor do they predict tt performance decrease in 
hypoxia.
We found no correlation between PetcO2 and other 
variables in our study, probably because the decrease in 
PetcO2 in hypoxia was too small (Fig. 2h) to provoke a 
significant vasoconstriction in the cerebral vasculature. 
the increase in McAv associated with hypoxia, increased 
Fig. 5  correlation between changes in cerebral tissue deoxy-
genation, cerebral blood flow velocity. a resting hypoxia (rH) vs. 
hypoxic exercise (EH) phases of the richalet test; b normoxic exer-
cise (En) vs. hypoxic exercise (EH). Middle cerebral artery blood 
flow velocity (McAv); Deoxyhemoglobin concentration (HHb)
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Fig. 6  Average values of heart 
rate (top panel), arterial O2 
saturation (middle panel), and 
power output (bottom panel) 
during 15 km time-trial in 
normoxia and hypoxia. Solid 
line: normoxic control room air 
(con), dashed line: hypoxic trial 
(Hx). Asterisks different from 
normoxia (p < 0.05)
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cardiac output and systemic blood pressure during exer-
cise would also counteract the vasoconstrictive effect of 
reduced PetcO2.
Although McAv and cerebral nIrS variables during 
the richalet test were not predictive of performance, these 
variables are of interest in order to characterize the cBF 
response to hypoxia, which is normally difficult to test, as 
cBF is normally insensitive to acute hypoxia during rest, 
unless hypoxia is very severe (PetO2 < 50 mmHg). Further 
studies are needed to determine whether specific nIrS or 
McAv responses to hypoxia would be predictive of altitude 
sickness.
Exercise limitation in severe hypoxia
the impairment of aerobic power and exercise perfor-
mance in severe hypoxia (SaO2 < 75, 66 % in the present 
study) is still not well understood (Amann et al. 2007; 
calbet et al. 2009). While the lack of oxygen is the obvi-
ous cause, the exact mechanisms by which hypoxia initi-
ates an earlier disengagement from an exercise challenge 
remain unclear. Since biochemical, electromyographic, 
and mechanical signs of muscle fatigue at exhaustion 
are lower compared to normoxia, muscle metabolic 
fatigue does not appear to be the main cause of impaired 
whole-body exercise performance in severe hypoxia 
(Verges et al. 2012). Upon reaching exhaustion in severe 
hypoxia, subjects can continue cycling when surrepti-
tiously switched to normoxia and/or hyperoxia (Kay-
ser et al. 1994; Amann et al. 2007; Subudhi et al. 2008; 
Koglin and Kayser 2013), which supports the role of 
supra-spinal limitation in exercise performance. Amann 
et al. (2007) speculated that the degree of hypoxia influ-
ences the relative role of muscle fatigue in the cessation 
of dynamic exercise with large muscle groups. they 
noted that similar levels of muscle fatigue were observed 
at task failure from constant load exercise to exhaus-
tion, when SaO2 averaged 94, 82, or 76 %, respectively 
(FIO2 = 0.21–0.12), but less muscle fatigue at a SaO2 of 
67 % (FIO2 = 0.10). From this, they reasoned that there 
is a threshold of SaO2 for a switch from a predominant 
effect of peripheral fatigue to a predominant effect in the 
cnS. In the present study both SaO2 and HHb concentra-
tions during the 15 km tt correlated to performance in 
hypoxia. Since SaO2 during the tt dropped well below 
the 75 % threshold proposed by Amann et al. (2007), 
tt performance was likely curtailed by some degree of 
cnS based limitation to motor drive. Since nIrS vari-
ables reflect a mean between pre- and post-capillary 
states, therefore potentially including mechanisms for O2 
extraction, there might be a role of adaptive oxygenation 
fraction extraction in hypoxia.
In similar conditions of severe hypoxia (SaO2 < 75 %), 
calbet et al. (2009) found that the reduction in systemic 
and leg O2 delivery during cycling corresponded with 
the reduction in V˙O2 peak. Since V˙O2 peak was reached 
at submaximal cardiac output as compared to normoxia, 
they speculated that the impaired maximal cardiac output, 
leg blood flow, O2 delivery to the leg muscles, and subse-
quent reduced V˙O2 peak and exercise performance could 
be attributed to a cardio-inhibitory reflex associated with 
lower brain O2 delivery in severe acute hypoxia.
In agreement with this hypothesis we found a decrease 
in brain oxygenation in our setup and a correlation between 
the change in prefrontal brain HHb between normoxic and 
hypoxic tt and the drop in tt performance (Fig. 7b). 
Fig. 7  correlation between the changes in average power output, 
arterial O2 saturation (top panel), and cerebral tissue deoxygenation 
(bottom panel) during the 15 km time-trial. Arterial oxygen saturation 
(SaO2); Deoxyhemoglobin concentration (HHb)
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However, we found no significant correlation between the 
changes in McAv and performance. the latter might be 
due to the strong increase in McAv during intense exercise, 
equally in normoxia and hypoxia. We recently reported 
that augmenting FIcO2 led to an increase in cBF dur-
ing submaximal exercise in normoxia, but not in hypoxia, 
indicating that the ‘normal’ cerebrovascular response to 
hypercapnia (i.e., vasodilation) is blunted during exer-
cise in hypoxia, possibly due to an exhaustion of cerebral 
vasodilatory reserve (Fan and Kayser 2013). If severe 
hypoxia cannot increase McAv further than that resulting 
from intense exercise, it may explain the lack of correla-
tion between hypoxic-normoxic McAv differences and tt 
performance.
Hypoxic ventilatory response and performance at altitude
Schoene et al. (1984) reported that climbers with a 
strong hypoxic ventilatory response were more success-
ful on Everest, reaching and sleeping at higher altitudes. 
Meanwhile, Bernardi et al. (2006) measured the venti-
latory response to hypoxia in 11 elite climbers attempt-
ing Everest and K2 and found that the successful climb-
ers (i.e., those summiting without using bottled oxygen) 
had lower resting minute ventilation, respiratory rate, and 
ventilatory response to hypoxia, and higher ventilatory 
reserve and ventilatory efficiency at 5,200 m, compared 
to the non-summiteers. those authors concluded that a 
blunted hypoxic ventilatory response at moderate altitude 
was advantageous for these summiteers, as it meant that 
they had a greater ventilatory reserve at lower altitudes, 
thereby permitting more sustainable ventilations near the 
summits. Since there was no difference in the hypoxic 
ventilatory response at low altitude prior to acclimatiza-
tion, it appears that this blunted ventilation at altitude was 
likely to be an adaptive response rather than a constitu-
tive characteristic (Bernardi et al. 2006). Additionally, 
Hornbein et al. (1989) suggested that a strong ventilatory 
response may lead to such important drops in PacO2 that 
hypocapnic cerebral vasoconstriction dominates hypoxic 
vasodilation, leading to excessive tissue hypoxia, and 
impaired neurobehavioral function and residual effects 
upon return from a prolonged altitude exposure. Van Dorp 
et al. (2007) found improved cognitive performance in 
hypoxia when adding cO2 to inspirate, suggesting that 
the balance between hypoxia-induced vasodilation and 
hypocapnia-induced vasoconstriction is indeed important. 
In the present study, the hypoxic stimulus was unlikely 
to be strong enough to reach ventilatory reserve and the 
intensity of exercise during the richalet test was not suffi-
cient to obtain a convincing correlation between the vari-
ations in SpO2 and V˙E or HVre as defined by richalet 
et al. (2012).
limitations
the richalet test was originally designed to predict sus-
ceptibility for altitude illness (richalet et al. 2012). In 
predisposed subjects and those who ascend too quickly, 
AMS develops between four and height hours after 
arrival to altitudes above 2,500–3,500 m (Hackett et al. 
1976). In our experimental design, the tt was performed 
after about 5 min of exposure to normobaric hypoxia, 
which is too short for AMS symptoms to develop. 
Whether cBF and brain oxygenation reactivity during 
a richalet test relate to AMS during a prolonged stay 
at altitude remains an open question. the relationship 
between richalet test results and the risk for AMS was 
evaluated on thousands of measurements (richalet et al. 
2012). Because of the limited number of subjects in our 
study we cannot exclude the possibility that the lack of 
correlation between cBF and cerebral oxygenation indi-
ces during the richalet test with time-trial performance 
might be due to type-II error.
We opted to use the original richalet test altitude of 
4,800 m but tested performance at 5,000 m. According to 
the measured FIO2 the actual difference between the two 
simulated altitudes was 165 m. Since the richalet test 
yields the same outcome at different simulated altitudes 
this should not have influenced the results (richalet et al. 
2012).
We used left prefrontal HHb and O2Hb measured by 
nIrS as indicators of global cerebral tissue oxygenation, 
which is a simplification, even though good agreements 
have been found between nIrS and fMrI measurements 
of cerebral tissue oxygenation levels over various cortices 
(Kleinschmidt et al. 1996; Strangman et al. 2002). nIrS 
bears further limitations (Bourdillon and Perrey 2012) such 
as bias from skin blood flow variations, since the light trav-
erses the skin and the bone layers before entering the tissue 
of interest. According to tew et al. (2010) such changes due 
to skin effects can be considered negligible compared to the 
changes in the brain tissue.
Since the two McAs supply ~80 % of global cBF 
(lindegaard et al. 1987), we used transcranial Doppler 
ultrasound to measure bilateral McAv as an index of 
global cBF changes. McAv has been shown to reflect 
changes in cBF assessed with the direct Fick method dur-
ing initial exposure to high altitude (roy et al. 1968). Sato 
et al. (2012) found good agreement between McAv and 
internal carotid artery blood flow changes (measured by 
duplex ultrasonography) during exercise from moderate 
(60 % V˙O2peak) to high intensity (80 % V˙O2peak). they 
further demonstrated that the relative contribution of the 
internal carotid artery (and therefore McA) to global cBF 
remained relatively unchanged (~65 %) at high intensity 
exercise. As such, we contend that McAv is a reasonable 
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index of changes in global cBF from rest to heavy exer-
cise. nevertheless, we cannot exclude variations between 
different areas of the brain.
During the richalet test and the tt we measured SpO2 
with an oximeter. Only during the tt we repeatedly meas-
ured SaO2 in capillary earlobe blood samples. Since dur-
ing the tt SpO2 dropped below 65 %, below the range 
in which values are reliable (70 to 100 % following the 
manufacturer’s instructions), we used SaO2, collected at 
rest and at 5th, 10th, and 15th km of the tt. SaO2 was not 
corrected for temperature changes during the tt; however, 
an increase in body core temperature from 37 to 39 °c dur-
ing exercise would only have modified SaO2 from 0.968 
to 0.970 in normoxia and from 0.640 to 0.641 in hypoxia 
[estimations made using the OSA program, (Siggaard-
Andersen 1974, 2003)].
Perspectives
there may be a trade-off between aerobic performance at 
moderate high altitude and extreme altitude, the former 
improving with a brisk ventilatory response to hypoxia, the 
latter with a blunted response. It would therefore be inter-
esting to relate the routine results of the richalet test not 
only to altitude illness but also to altitude performance (for 
example highest altitude reached, summit success) and to 
complement the test with cBF, frontal lobe nIrS measure-
ments and cognitive performance tests, if possible repeated 
upon return from altitude.
Conclusions
We found that the results of the richalet test were not pre-
dictive of the impairment of 15 km time-trial cycling per-
formance in severe hypoxia. Since the hypoxia-caused 
decrease in SaO2 and in prefrontal brain HHb during the 
tt correlated with the decrease in tt performance, mass 
oxygen supply to the brain during the tt seemed limited 
by hypoxia, leaving the hypothesis that brain oxygenation 
may play a limiting role for global exercise in conditions of 
severe hypoxia to be tested further.
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